Sleep Disturbances in Dermatology Patients

Completed

• Conditions: Sleep Disorder

• Registration Number: NCT03903263
• Lead Sponsor: University Hospital, Basel, Switzerland

Brief Summary

This study is to investigate sleep disorders in patients with dermatologic diseases by taking into consideration dermatologic (itch, pain) and non- dermatologic (medication, depression) factors.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-09-21
• Primary Completion: 2019-01-31
• Study Completion: 2019-01-31
• Status Verified: 2019-04
• Study First Submitted: 2019-04-02
• Study First Submitted QC: 2019-04-02
• Study First Posted: 2019-04-04
• Last Update Submitted: 2019-04-10
• Last Update Posted: 2019-04-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 624

Inclusion Criteria

• Outpatients of the dermatologic university clinic

Exclusion Criteria

• Insufficient knowledge of German language
• Illiteracy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Regensburg Insomnia Scale (RIS)	single time point assessment at baseline	Self-rating scale: Five items cover quantitative and qualitative sleep parameters: Sleep latency (1), sleep duration (2), sleep continuity (3), early awakening (4) and sleep depth (5). Four items cover the psychological aspects of psychophysiological insomnia (PI), such as the experience of sleepless nights (6), focussing on sleep (7), fear of insomnia (8), and daytime fitness (9), one item covers sleep medication (10). A 5-step Likert scale was provided for response.The total score ranges from 0 to 40 points (score from 0-12 points considered as normal and a higher score as indicative of PI symptoms).

Trial Locations

Locations (1)

Department of Dermatology, University Hospital Basel; 🇨🇭 Basel, Switzerland